Last quarter (Q4 2023), T Rowe Price's total revenue was $1.64B, an increase of 7.73% from the same quarter last year. In Q4, T Rowe Price's net income was $-1.36B. See T Rowe Price’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 6.14B	$ 6.46B	$ 6.49B	$ 7.10B	$ 6.21B	$ 5.62B
Cost of Revenue	-	-	$ -2.92B	-	$ 2.62B	$ 2.38B
Gross Profit	$ 6.46B	$ 6.46B	$ 3.57B	$ 7.67B	$ 3.59B	$ 3.23B
Operating Expense	$ 4.47B	$ 4.47B	$ -1.07B	$ 3.96B	$ 844.60M	$ 846.00M
Operating Income	$ 2.51B	$ 1.99B	$ 2.50B	$ 3.71B	$ 2.75B	$ 2.39B
Net Non Operating Interest Income Expense	$ 139.30M	-	-	$ 290.50M	-	-
Other Income Expense	$ -447.20M	$ -586.50M	$ 547.80M	$ 5.90M	$ 496.50M	$ 540.30M
Pretax Income	$ 2.49B	$ 2.49B	$ 1.95B	$ 3.99B	$ 3.24B	$ 2.93B
Tax Provision	$ 654.60M	$ 654.60M	$ 498.60M	$ 896.10M	$ 718.90M	$ 678.40M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 607.90M	$ 1.79B	$ 1.52B	$ 3.08B	$ 2.31B	$ 2.08B
Basic EPS	$ 7.84	$ 7.78	$ 6.73	$ 13.25	$ 10.08	$ 8.82
Diluted EPS	$ 7.81	$ 7.76	$ 6.70	$ 13.12	$ 9.98	$ 8.70
Basic Average Shares	$ 896.40M	$ 224.10M	$ 226.00M	$ 226.60M	$ 228.80M	$ 235.40M
Diluted Average Shares	$ 899.20M	$ 224.80M	$ 227.10M	$ 228.80M	$ 231.20M	$ 238.60M
Dividend Per Share	$ 4.88	$ 4.88	$ 4.80	-	$ 3.60	$ 3.04
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	$ 9.58	$ 8.07
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 4.47B	$ 4.47B	$ 4.11B	$ 3.96B	$ 3.46B	$ 3.23B
Net Income From Continuing And Discontinued Operation	$ 1.81B	$ 1.79B	$ 1.56B	$ 3.10B	$ 2.37B	$ 2.13B
Normalized Income	$ 1.45B	$ 1.88B	$ 1.38B	-	$ 1.98B	$ 1.72B
Interest Expense	-	-	-	-	-	-
EBIT	$ 2.49B	$ 2.49B	$ 1.95B	$ 3.99B	$ 2.75B	$ 2.39B
EBITDA	$ 2.97B	$ 2.97B	$ 2.59B	$ 4.20B	$ 2.94B	$ 2.58B

Currency in USD

T Rowe Price Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing